Drug intelligence / Profile preview

Denpro

Development stage: Unknown
Lead developer: Gennec Health Sciences
Modality: Small Molecules
Administration: Topical

Overview

Denpro (Denpro oral gel) is a natural herbal-based topical medication developed for the treatment of oral ulcers (aphthous stomatitis). Formulated as a gel, it is applied directly to the affected oral mucosa 2-4 times daily to facilitate healing and reduce the size of the ulcerated area. Clinical trial data indicates that the gel promotes the complete recovery of the oral mucosa, with significant reduction in ulcer size observed over a two-to-four-week treatment period. The product is manufactured by Gennec Health Sciences and has been evaluated in clinical settings for its efficiency and biocompatibility as a natural therapeutic alternative to conventional treatments.

Brand names: Denpro
Other names: Denpro oral gel

Beyond the preview

Go deeper on Denpro.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Denpro.

Explore the full profile